A law enforcement officer inspects vaccines at the Center for Disease Control and Prevention in Rong'an county of Liuzhou city in the Guangxi Zhuang autonomous region. (Photo by Tan Kaixing/China Daily)
Vaccine maker Changsheng Biotechnology received a mandatory delisting notification from the Shenzhen Stock Exchange, according to the bourse's website on Tuesday.
Changsheng Biotechnology, a major vaccine producer based in Changchun, Jilin, was involved in a vaccine safety scandal when the State Drug Administration announced it found the company had engaged in falsifying production and inspection records in the making of vaccines.
